48 reports

As mentioned above, the other forms of amyloidosis are treated with off-label MM strategies, stem cell/ organ transplants, or treating underlying causes, all of which are beyond the scope of this report.

  • Cardiology
  • United States
  • Forecast
  • Alnylam Pharmaceuticals, Inc.
  • Pfizer Inc.

One of its unit that is, Milano Cord Blood Bank (MCBB), is one of the largest cord blood bank in Europe with more than ##, ## cord blood units available for transplantation.

  • Cardiology
  • World
  • Market Size
  • Amgen Inc.
  • Celgene Corporation

Exogenous neural stem cells are transplanted into the patient, which helps in tissue regeneration or replacement.

  • Cardiology
  • North America
  • United States
  • Market Size
  • Evonik Industries AG

stem cells II; autologous human mesenchymal stem cells University of Miami ## Mar 2025 ## Mar 2030 ## ## ## Hybrid Biotherapy Involving Autologous Human Cardiac Stem Cell Transplantation Using a Gelatin Hydrogel Sheet to Treat Sev

  • Cardiology
  • Cardiovascular Disease
  • World
  • Product Initiative
  • Eli Lilly & Co.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

The stem cells are differentiated and expanded from the patient' s blood and then re-injected into the diseased tissue.

  • Cardiology
  • Drug Development
  • Pharmaceutical
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

stem cells II; autologous human mesenchymal stem cells University of Miami ## Mar 2025 ## Mar 2030 ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Ph

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Drug Development
  • World

Safety Assessment. a Randomised, Double Blind Placebo-controlled Single Center Pilot Clinical Trial Reparative Therapy in Acute Ischemic Stroke with Allogenic Mesenchymal Stem Cells from Adipose Tissue.

  • Cardiology
  • Clinical Trial
  • Drug Development
  • World
  • Otsuka Pharmaceutical Co., Ltd.

Hoffmann-La Roche Ltd ## Oct 2010 ## Aug 2012 ## ## ## ## ## Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) Inhibitor Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) Umbilical Cord Blood Stem Cell Injection for Critica

  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Cardiology
  • Pharmaceutical
  • Salicylic Acid
  • World
  • Product Initiative
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database
  • CLINICAL TRIAL PROFILE SNAPSHOTS

A Phase I Study Stem Cell Injection for Peripheral Vascular Disease GDCT## NCT##, PVD.

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Therapy
  • World

Braun Melsungen AG AstraZeneca Plc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ascorbic acid alone or in combination has the highest number of septic shock ongoing clinical trials.

  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients with Idiopathic Dilated Cardiomyopathy and Heart Failure.

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Hospital
  • MyoKardia, Inc.

Auto2002 Cardiovascular Behcet Disease, Churg-Strauss Syndrome, Cryoglobulinemia, Giant Cell Arteritis (Temporal Arteritis/ Cranial Arteritis/ Horton Disease), Granulomatosis with Polyangiitis (Wegener' s Granulomatosis), Microscopic Polyangiitis (MPA), Sicca Syndrome (Sjogren),

  • Cardiology
  • Clinical Trial
  • Drug Development
  • Medical Biotechnology
  • World

National Institutes of Health ## Jul 2001 ## Dec 2006 ## ## ## ## Endothelin ## Receptor (Endothelin A Receptor or EDNRA) Antagonist Endothelin ## Receptor (Endothelin A Receptor or EDNRA) Impact of Cholecalciferol on Endothelial Fucntion and Blood Biomarkers in Patients wit

  • Cardiology
  • Clinical Trial
  • Medical Biotechnology
  • Pharmaceutical
  • World

Auto2002 Cardiovascular Behcet Disease, Churg-Strauss Syndrome, Cryoglobulinemia, Giant Cell Arteritis (Temporal Arteritis/ Cranial Arteritis/ Horton Disease), Granulomatosis with Polyangiitis (Wegener' s Granulomatosis), Microscopic Polyangiitis (MPA), Sicca Syndrome (Sjogren),

  • Cardiology
  • Clinical Trial
  • Medical Biotechnology
  • Therapy
  • World

The prominent features of this report are - ##.

  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • World
  • Product Initiative

Key data was presented at the conference in two poster presentations entitled: PBI-## Reduces Angio-proliferative Pulmonary Arterial Hypertension: Decreased Human Pulmonary Artery Smooth Muscle Cell Proliferation and Microvascular Endothelial Cell endoplasmic reticulum stress Tra

  • Cardiology
  • Clinical Trial
  • Hypertension
  • Pharmaceutical
  • World

stem cells, aspirin, allopurinol and allogeneic adipose derived stem cells alone or in combination have the highest number of chronic coronary artery disease (cad) (ischemic heart disease) ongoing clinical trials.

  • Cardiology
  • Cardiovascular Disease
  • Coronary Artery Disease
  • World
  • Product Initiative

VASO-OCCLUSIVE CRISIS ASSOCIATED WITH SICKLE CELL DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN G## COUNTRIES VASO-OCCLUSIVE CRISIS ASSOCIATED WITH SICKLE CELL DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* VASO-

  • Blood Disease
  • Cardiology
  • Therapy
  • World
  • Product Initiative

## heparin hematopoietic stem cells dabigatran etexilate mesylate Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of September 2017 ## ##

  • Cardiology
  • Digestive System Disorder
  • World
  • Product Initiative
  • Jazz Pharmaceuticals plc

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cardiology
  • Clinical Trial
  • Hospital
  • Therapy
  • World
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients (ICMNC-HF) GDCT## NCT##, SCARM-Heart-## Cardiovascular Atherosclerosis, Congestive Heart Failure (Heart Failure), Coronary Artery Disease (CAD) (Ischemic Heart Disease), Myocardial Infarction Planned Phas

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Lipid Modifying Drug
  • World

McNiece has spent ## years in both academic and commercial settings working in the areas of stem cell biology and clinical manufacturing for bone marrow transplantation and cellular therapy clinical applications.

  • Cardiology
  • Peripheral Vascular Device
  • North America
  • United States
  • Becton Property Group
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

A Phase I Study Stem Cell Injection for Peripheral Vascular Disease GDCT## NCT##, PVD.

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Therapy
  • World
  • Official Title

The prominent features of this report are - ##.

  • Blood Disease
  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • World

UCSF serves in the areas of cancer, children' s health, diabetes, heart and vascular immunology and infectious diseases stem cells, transplant services, neurology and neurosurgery translational medicine and women' s health.

  • Cardiology
  • Clinical Trial
  • Medical Device
  • United States
  • Boston Scientific Corporation
  • 5. All the trials included are unique trials.

A Phase I Study Stem Cell Injection for Peripheral Vascular Disease GDCT## NCT##, PVD.

  • Cardiology
  • Cardiovascular Disease
  • Clinical Trial
  • Drug Development
  • World

The prominent features of this report are - ##.

  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • Hypertension
  • World

Its stem cell programmes are based on a validated platform of allogeneic expanded adipose-derived stem cells (eASCs) targeting autoimmune and inflammatory diseases.

  • Cardiology
  • Neurology
  • United States
  • M&A
  • Takeda Pharmaceutical Company Limited

Safety Assessment. a Randomised, Double Blind Placebo-controlled Single Center Pilot Clinical Trial Reparative Therapy in Acute Ischemic Stroke with Allogenic Mesenchymal Stem Cells from Adipose Tissue.

  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • Stroke
  • World